title: Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.
abstract: Apraxia of speech is a disorder of speech motor planning and/or programming that is distinguishable from aphasia and dysarthria. It most commonly results from vascular insults but can occur in degenerative diseases where it has typically been subsumed under aphasia, or it occurs in the context of more widespread neurodegeneration. The aim of this study was to determine whether apraxia of speech can present as an isolated sign of neurodegenerative disease. Between July 2010 and July 2011, 37 subjects with a neurodegenerative speech and language disorder were prospectively recruited and underwent detailed speech and language, neurological, neuropsychological and neuroimaging testing. The neuroimaging battery included 3.0 tesla volumetric head magnetic resonance imaging, [(18)F]-fluorodeoxyglucose and [(11)C] Pittsburg compound B positron emission tomography scanning. Twelve subjects were identified as having apraxia of speech without any signs of aphasia based on a comprehensive battery of language tests; hence, none met criteria for primary progressive aphasia. These subjects with primary progressive apraxia of speech included eight females and four males, with a mean age of onset of 73 years (range: 49-82). There were no specific additional shared patterns of neurological or neuropsychological impairment in the subjects with primary progressive apraxia of speech, but there was individual variability. Some subjects, for example, had mild features of behavioural change, executive dysfunction, limb apraxia or Parkinsonism. Voxel-based morphometry of grey matter revealed focal atrophy of superior lateral premotor cortex and supplementary motor area. Voxel-based morphometry of white matter showed volume loss in these same regions but with extension of loss involving the inferior premotor cortex and body of the corpus callosum. These same areas of white matter loss were observed with diffusion tensor imaging analysis, which also demonstrated reduced fractional anisotropy and increased mean diffusivity of the superior longitudinal fasciculus, particularly the premotor components. Statistical parametric mapping of the [(18)F]-fluorodeoxyglucose positron emission tomography scans revealed focal hypometabolism of superior lateral premotor cortex and supplementary motor area, although there was some variability across subjects noted with CortexID analysis. [(11)C]-Pittsburg compound B positron emission tomography binding was increased in only one of the 12 subjects, although it was unclear whether the increase was actually related to the primary progressive apraxia of speech. A syndrome characterized by progressive pure apraxia of speech clearly exists, with a neuroanatomic correlate of superior lateral premotor and supplementary motor atrophy, making this syndrome distinct from primary progressive aphasia.
authors.affiliation: Behavioural Neurology and Movement Disorders, Mayo Clinic, 200 1st Street S.W., Rochester, MN 55905, USA. Josephs.keith@mayo.edu
authors.forename: Keith A
authors.initials: KA
authors.lastname: Josephs
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Duffy
authors.forename: Edythe A
authors.initials: EA
authors.lastname: Strand
authors.forename: Mary M
authors.initials: MM
authors.lastname: Machulda
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Senjem
authors.forename: Ankit V
authors.initials: AV
authors.lastname: Master
authors.forename: Val J
authors.initials: VJ
authors.lastname: Lowe
authors.forename: Clifford R
authors.initials: CR
authors.lastname: Jack
authors.forename: Jennifer L
authors.initials: JL
authors.lastname: Whitwell
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000814:Aniline Compounds; D001072:Apraxias / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology*; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D038524:Diffusion Magnetic Resonance Imaging; D018450:Disease Progression; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007807:Language Tests; D008297:Male; D008875:Middle Aged; D019636:Neurodegenerative Diseases / Q000150:complications*; D009460:Neurologic Examination; D009483:Neuropsychological Tests; D049268:Positron-Emission Tomography; D013064:Speech Disorders / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology*; D013844:Thiazoles; D014057:Tomography, X-Ray Computed
chemical_list: C475519:2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole; D000814:Aniline Compounds; D013844:Thiazoles; D019788:Fluorodeoxyglucose F18